ホーム › 小細胞肺がん › ニューヨーク

ニューヨークにおける小細胞肺がんの臨床試験

ニューヨーク内の拠点で、小細胞肺がんに関する31件の研究が参加者を募集しています。

ニューヨーク内の都市

公式研究テキスト（英語）

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

MSK Commack, Commack
MSK Westchester, East White Plains
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy, Long Island City
他3件

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07476287

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

GSK Investigational Site, East Syracuse

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07099898

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

START New York, Lake Success

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07488676

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

START New York, Lake Success

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/18更新 · NCT07730021

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

Roswell Park Cancer Institute, Buffalo

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/14更新 · NCT07325136

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Stony Brook Cancer Center, Stony Brook
Montefiore Medical Center, The Bronx

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/14更新 · NCT07218146

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Roswell Park Cancer Institute ( Site 1107), Buffalo

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/09更新 · NCT06780137

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, New York

被験者募集中第1/2相

18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343

A Study of Armored CAR T Cells in People With Cancer

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/02更新 · NCT07783477

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
White Plains Hospital, White Plains

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Montefiore Medical Center- Montefiore Medical Park, The Bronx

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/28更新 · NCT07057791

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Memorial Sloan Kettering, New York

被験者募集中第1/2相

18歳〜100歳 · 全性別 · 2026/08/27更新 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Memorial Sloan Kettering Cancer Center (MSKCC), New York
Icahn School of Medicine at Mount Sinai PRIME, New York

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/26更新 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NYU Langone Health, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/25更新 · NCT07488923

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

New York University Cancer Institute, New York

被験者募集中第1相

18歳〜99歳 · 全性別 · 2026/08/21更新 · NCT07531095

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Memorial Sloan Kettering Cancer Center, New York

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/12更新 · NCT04199741

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Cancer Center, New York
他1件

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/11更新 · NCT06807632

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Clinical Research Alliance, Inc, Lake Success
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
New York University Cancer Center - Laura and Isaac, New York
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/06更新 · NCT06203210

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Montefiore Medical Center, The Bronx

被験者募集中第2相

18歳以上 · 全性別 · 2026/07/23更新 · NCT05882058

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Columbia University Medical Center - Herbert Irving Pavilion, New York

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/07/09更新 · NCT07174583

A Study of LY4175408 in Participants With Advanced Cancer

Columbia University, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923

A Study of Hospital-at-Home for People Receiving Tarlatamab

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
他1件

被験者募集中

18歳以上 · 全性別 · 2026/06/12更新 · NCT06957314